SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-007057
Filing Date
2022-06-29
Accepted
2022-06-29 18:14:04
Documents
1
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 form3-06292022_030649.html 3  
1 form3-06292022_030649.xml 3 4007
  Complete submission text file 0001415889-22-007057.txt   5457
Mailing Address 12 HARVEY DRIVE SHORT HILLS NJ 07078
Business Address
VAN VOORHEES SETH (Reporting) CIK: 0001284934 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38302 | Film No.: 221055974

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations